1. Predicting Mesothelioma Survival with FDG PET/CT
October 31, 2013
Another study suggests that FDG PET/CT scans can be a powerful predictor of survival in malignant pleural mesothelioma. FDG PET/CT uses a radioactive glucose analog tracer molecule and two types of imaging studies to gather important information about tumors. The FDDG PET test is based on the fa...
|
 |
 |
2. Mesothelioma Unaffected by Aspirin Derivative
October 29, 2013
Mesothelioma researchers in Italy have been disappointed in their efforts to fight malignant mesothelioma with an aspirin derivative.
A number of studies have suggested that aspirin may play a role in the fight against certain cancers. But the Italian team testing an aspirin derivative calle...
|
|
|
3. Too Heated Chemo May Work for Pleural Mesothelioma
October 24, 2013
A procedure that involves putting heated chemotherapy drugs in direct contact with the site of a mesothelioma tumor after surgery may improve the outlook for people with malignant pleural mesothelioma.
A similar procedure is already being used to treat people with peritoneal mesothelioma, a ...
|
|
|
4. Experimental Drug May Boost Chemotherapy for Mesothelioma
October 21, 2013
British cancer researchers are hopeful that a new drug called ganetespib will give a boost to patients undergoing standard chemotherapy for malignant pleural mesothelioma.
Mesothelioma, a virulent cancer caused by asbestos, is diagnosed at a higher rate in the UK than anywhere else in the wo...
|
|
|
5. Healthy Weight Better for Mesothelioma Survival
October 17, 2013
Maintaining a healthy weight may improve the odds for survival among patients battling malignant pleural mesothelioma.
A recent Associated Press report suggests that obese patients are likely to receive less chemotherapy than they need because of doctors’ fears of overdosing. According to th...
|
|
|
6. Study Finds Starvation Enhances Chemotherapy for Mesothelioma
October 14, 2013
A study in Switzerland appears to indicate that depriving mesothelioma cells of nutrition makes them more sensitive to treatment with cisplatin-based chemotherapy. The research team studied the effects of combining chemotherapy and starvation in human mesothelioma cells, both in test tubes and in li...
|
|
|
7. Drug Targets are Hopeful News for Mesothelioma
October 10, 2013
Mesothelioma patients may have a new drug treatment option sooner thanks to the FDA. The agency has approved a request from drug manufacturer Verastem to grant orphan drug status to VS-6063. The oral drug is designed to inhibit a critical signaling pathway inside the stem cells where cancer starts. ...
|
|
|
8. Mesothelioma: New Orphan Drug and New Drug Target
October 03, 2013
A drug that fights cancer by attacking the stem cells that give rise to it has been granted orphan drug status for mesothelioma.
The oral drug VS-6063 inhibits a crucial signaling pathway inside stem cells called the Focal Adhesion Kinase (FAK) pathway. By killing the stem cells that lead to...
|
|
|
9. UK Rise is Mesothelioma Cases Called "Shocking"
September 30, 2013
The Greater Manchester area in England has seen a 55 percent rise in the number of mesothelioma cases diagnosed in the last 5 years.
Mesothelioma is an aggressive cancer and the most deadly of the illnesses associated with asbestos exposure. A Manchester-area online news source, Rochdale Onl...
|
|
|
10. Sharp Rise in Mesothelioma Cases for UK
September 23, 2013
While the incidence of malignant mesothelioma is beginning to decline in the US, the deadly asbestos cancer is still on the rise in the UK. Rochdale Online is reporting a 55 percent increase in mesothelioma cases in the Greater Manchester area in the last 5 years. A total of 138 people were diagnos...
|
|
|
Author: henric edson
